An international collaboration and a single patient with mild muscle disease and severe cognitive impairment have allowed researchers to identify a new gene mutation that causes muscular dystrophy. Furthermore, by engineering the human gene mutation into mice, the researchers have created a new mouse model that could help screen potential drugs to treat this type of muscular dystrophy.